-
- Research/Project Funding Opportunity
- Posted 1 day ago
Notice of Early Expiration of PAR-23-081, "Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 1 day ago
Notice of Early Expiration of RFA-DK-21-033 "KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Independent Clinical Trial Not Allowed)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 4 weeks ago
Notice of Early Expiration of PAR-23-165 " Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 4 weeks ago
Notice of Early Expiration of PAR-24-088, "Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 4 weeks ago
Notice of Early Expiration of PAR-23-050, "Clinical Studies of Mental Illness (Collaborative R01) (Clinical Trial Optional)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 1 month ago
Notice of Early Expiration of RFA-OD-23-017 "Tobacco Regulatory Science (R01 Clinical Trial Optional)"
at National Institutes of Health in États-Unis -
- Fellowship
- Posted 1 month ago
Notice of Early Expiration of "Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application", NOT-HG-24-012
at National Institutes of Health in États-Unis -
- Fellowship
- Posted 3 months ago
Notice of Early Expiration of NOT-CA-24-060 - Notice of Special Interest (NOSI): Advancing Diet and Physical Activity Biomarkers for Assessing Lifestyle Interventions in Cancer Prevention and Cancer Interception Research
at National Institutes of Health in États-Unis -
- Contract/Tender
- Posted 7 months ago
Notice of Early Expiration of "Notice of Special Interest (NOSI): Molecular and Genetic Characterization of Inborn Errors of Immunity", NOT-AI-21-082
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 8 months ago
Notice of Early Expiration of PAR-23-118 "National Centers for Cryoelectron Microscopy (R24 Clinical Trial Not Allowed)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 8 months ago
Notice of Early Expiration of RFA-HG-22-027, "Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 8 months ago
Notice of Early Expiration of RFA-HG-22-026, "Diversity Centers for Genome Research (U54 Clinical Trials Optional)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Early Expiration of PAR-22-248: HIV/AIDS Scholars Using NHP Models Program (K01 Independent Clinical Trial Not Allowed) and PAR-22-252: Early Stage Investigator HIV/AIDS Research Using NHP Models (R21 Clinical Trial Not Allowed)
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Early Expiration of RFA-HG-21-041 "New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)"
at National Institutes of Health in États-Unis -
- Contract/Tender
- Posted 1 year ago
Notice of Early Expiration of NOT-HD-22-043 "Notice of Special Interest ( NOSI ): Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE initiative"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Early Expiration and Reissue of RFA-DA-22-038, "Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Early Expiration of PAR-20-100 Genomic Community Resources (U24 Clinical Trial Not Allowed)
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Early Expiration of PAR-20-097 "Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Early Expiration of PAR-20-089 "Biomedical Data Repository (U24 - Clinical Trials Not Allowed)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Early Expiration of RFA-NS-21-022 "Translational Neural Devices (U44 Clinical Trial Optional)"
at National Institutes of Health in États-Unis -
- Contract/Tender
- Posted 1 year ago
Notice of Early Expiration of "Notice of Special Interest (NOSI): Complement in Basic Immunology (CIBI)", NOT-AI-21-008
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Early Expiration of RFA-HG-21-001, Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial Not Allowed)" and RFA-HG-21-002, Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial Not Allowed)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Early Expiration of RFA-AI-21-035, Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Early Expiration of RFA-AI-21-020, Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)"
at National Institutes of Health in États-Unis